FDA Inspection 1069126 — New York Blood Center, Inc.
The FDA completed an inspection of New York Blood Center, Inc. on Sep 18, 2018 in Paramus, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 18, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Paramus, NJ (United States)